SpectraCure AB (publ) (STO:SPEC)
Sweden · Delayed Price · Currency is SEK 0.0900
+0.0023 (2.62%)
Mar 24, 2026, 5:23 PM CET
SpectraCure AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
51.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 539.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 1.21M | 448.00K | 58.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 489.70M |
| Arcoma AB | 130.80M |
| ScandiDos AB | 61.26M |
| Nosa Plugs AB | 24.12M |
| Clinical Laserthermia Systems AB | 17.49M |
| Perpetua Medical AB | 14.56M |
| Iconovo AB | 14.53M |
| Luxbright AB | 13.75M |